TNGX – tango therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at B. Riley from $16.00 to $8.00. They now have a "buy" rating on the stock.
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Tango Therapeutics, Inc. (NASDAQ: TNGX) had its price target lowered by analysts at Guggenheim from $18.00 to $8.00. They now have a "buy" rating on the stock.
Tango Therapeutics, Inc. (TNGX) Reports Q3 Loss, Tops Revenue Estimates [Yahoo! Finance]
Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights [Yahoo! Finance]
Form SC 13G Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC
Form 4 Tango Therapeutics, Inc. For: Nov 14 Filed by: Rothenberg Mace
Form 4 Tango Therapeutics, Inc. For: Nov 06 Filed by: EcoR1 Capital, LLC
Form SC 13D/A Tango Therapeutics, Inc. Filed by: Boxer Capital Management, LLC
Form 4 Tango Therapeutics, Inc. For: Nov 06 Filed by: Davis Aaron I.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.